Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m (171.1m) in the first nine months. The operating...
Hofseth Biocare ASA: CFO RESIGNATION Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company...
Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT Ålesund, Norway, 8 October 2024. HBC Immunology (HBCI) is pleased to announce the successful...
Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 80.4m (76.4m) in the second quarter and NOK 132.8m (121.2m) for the half year...
Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY Ålesund, Norway, 14 August, 2024 - Hofseth BioCare (HBC), a leader in...
Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine...
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY Hofseth BioCare ASA (HBC) is delighted to announce the appointment of Lithy One-Health Group Technology Co. Ltd...
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17...
Hofseth Biocare ASA: Annual General Meeting completed Hofseth BioCare ASA held its Annual General Meeting on 10 May 2024. 270,174,810 shares, amounting to 68.38 per cent of the share capital, were...
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024 The Annual General Meeting of Hofseth BioCare ASA for 2024 will be held at the company's premises at Keiser Wilhelms gate 24, 6003...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 2 | 2 | 2 | 0 | 0 | DE |
4 | 0 | 0 | 2 | 2 | 2 | 0 | 0 | DE |
12 | 0 | 0 | 2 | 2 | 2 | 2310 | 2 | DE |
26 | 0 | 0 | 2 | 2 | 2 | 1245 | 2 | DE |
52 | 0 | 0 | 2 | 2 | 2 | 1151 | 2 | DE |
156 | 0 | 0 | 2 | 2 | 2 | 646 | 2 | DE |
260 | 0 | 0 | 2 | 2 | 2 | 2644 | 2 | DE |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관